Supplemental material
Modern Rheumatology
Volume 30, 2020 - Issue 2
Open access
3,173
Views
16
CrossRef citations to date
0
Altmetric
Original Articles: Rheumatoid Arthritis
Sarilumab monotherapy or in combination with non-methotrexate disease-modifying antirheumatic drugs in active rheumatoid arthritis: A Japan phase 3 trial (HARUKA)
Hideto KamedaDivision of Rheumatology, Department of Internal Medicine, Faculty of Medicine, Toho University (Ohashi Medical Center), Tokyo, Japan; Correspondence[email protected]
View further author information
, View further author information
Kazuteru WadaSanofi K.K., Tokyo, Japan; View further author information
, Yoshinori TakahashiSanofi K.K., Tokyo, Japan; View further author information
, Owen HaginoSanofi, Bridgewater, NJ, USA; View further author information
, Hubert van HoogstratenSanofi-Genzyme, Cambridge, MA, USA; View further author information
, Neil GrahamRegeneron Pharmaceuticals, Inc., Tarrytown, NY, USA; View further author information
& Yoshiya TanakaFirst Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, JapanView further author information
show all
Pages 239-248
|
Received 13 Mar 2019, Accepted 01 Jul 2019, Published online: 24 Jul 2019
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.